
    
      objectives:

        1. To compare the response rates and toxicity of R-CHOP versus DA-EPOCH-R in untreated
           CD20+ diffuse large B-cell lymphomas.

        2. To compare the event-free survival of R-CHOP versus DA-EPOCH-R chemotherapy in untreated
           CD20+ diffuse large B-cell lymphomas.

        3. To develop predictors of outcome of R-CHOP and DA-EPOCH-R chemotherapy.
    
  